2016 Distinguished Pharmacy Alumni Awardee
Jeffrey E. Browne
Director, Science & Technology
Catalent Pharma Solutions
“Based on the excellent reputation of Purdue’s IPPH Department in the industry, I was fortunate to begin my career at The Upjohn Co. This first job, and my interaction with top notch scientists at Upjohn, really laid the foundation for my successes in the various job roles I have held over the last 35 years in the pharma industry.”
- BS, Pharmacy, Purdue University, 1975
- PhD, Industrial and Physical Pharmacy, Purdue University, 1979
- Receipt of PhD from the Department of Industrial and Physical Pharmacy
- Recipient of Catalent’s CEO Award in 2011
- Catalent President’s Club Winner and CEO Award in 2012
- Norvir Softgel Capsule reintroduction for HIV in 1999
- Relocation of Catalent Research and Development from Somerset, NJ to St. Petersburg, FL
After receiving his BS in Pharmacy and PhD in Industrial and Physical Pharmacy from Purdue University, Jeff Browne spent the first 11 years of his career working for The Upjohn Co. in Kalamazoo, Michigan. While at Upjohn, he held various positions in Pharmaceutical Manufacturing and Technical Services and Drug Delivery Research and Development with a focus on topical, transdermal, inhalation, and oral liquid dosage forms. For the next four years, he was Director of U.S. Technical Affairs for Rhoto Pharmaceutical Co. located in Osaka, Japan.
Since joining Catalent Pharma Solutions (formally RP Scherer and Cardinal Health Pharmaceutical Technologies and Services) in 1994, Jeff has held a variety of positions including: Vice President Softgel Research and Development in St. Petersburg, Florida; Executive Director and Division Head of Pharmaceutical Development in Research Triangle Park, North Carolina; Director of Technical Services in St. Petersburg, Florida; Account Director, Business Development; Technical Director, Pharmaceutical Softgels; Research and Development Director, U.S. Platform Lead, Pharmaceutical Softgels; and most recently Director of Science and Technology. He is a Catalent President’s Club Winner and a two time recipient of Catalent’s CEO Award.
Jeff is an active member of the American Association of Pharmaceutical Scientists (AAPS) of which he has served on several Focus Group committees and frequently presents at regional and national AAPS meetings.